A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

NCT06174987 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer

Interventions

DRUG: T-DXd

Sponsor

Daiichi Sankyo

Collaborators

[object Object]